<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Being cardiologists, it is of great concern to us whether COVID-19 is more common in patients with pre-existing CVD. Evidence from the previous epidemics suggests that SARS (2002) and MERS (2012) were commonly associated with prior cardiac and cerebrovascular abnormalities.
 <xref rid="bib9" ref-type="bibr">9</xref>, 
 <xref rid="bib10" ref-type="bibr">10</xref>, 
 <xref rid="bib11" ref-type="bibr">11</xref> In SARS, DM and CVD were seen in 11%, and 8% of patients, respectively, and the presence of either of them doubled the mortality.
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref> Similarly, in a systematic analysis involving 637 patients with MERS, the prevalence of DM, HTN, CVD, and obesity was 50%, 50%, 30%, and 16%, respectively.
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref>
</p>
